Overview (18 Sep 2026)
Kwality Pharmaceuticals Ltd
KPL
INE552U01010

Pharmaceuticals
24.05

Prev. Close
Previous Close
3451.35
Current Close
3475.4
Current High
3560.55
Current Low
3430
52 Week High
3771
52 Week Low
828.8
Resistance 1
3547.30
Resistance 2
3619.20
Support 1
3416.75
Support 2
3286.20
Std Deviation
10.19%
DMA 200
1953.74
DMA 50
3096.19
DMA 20
3419.88
Fundamentals and Ratios
Standalone
Trailing EPS
64.9
Forwad EPS
86
Trailing P/E
53.55
Forward P/E
40.41
PEG Ratio
0.96
Mkt. Cap (Cr)
Market Cap (Cr)
3606.14
Total Debt(Cr)
Tot. Debt(Cr)
112.45
Reserve (Cr)
253.67
Book Value
253.89
P/BV Ratio
13.69
ROCE(%)
31.00
ROE
44.00
Consolidated
Trailing EPS
38.36
Forwad EPS
54.01
Trailing P/E
90.6
Forward P/E
64.34
PEG Ratio
4.18
Mkt. Cap (Cr)
Market Cap (Cr)
3606.14
Total Debt(Cr)
Tot. Debt(Cr)
112.45
Reserve (Cr)
253.67
Book Value
253.89
P/BV Ratio
13.69
ROCE(%)
22.58
ROE
21.4100

 

Financial Result
Standalone
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue162.35156.82123.45111.31111.48503.06
Other Income0.621.060.530.900.382.86
Total Income162.98157.88123.97112.21111.86505.92
Interest2.662.892.482.842.7610.97
Expenditure-128.98-126.23-100.79-93.76-94.80-415.60
PBDT0.000.000.000.000.000.00
Depreciation-4.99-5.26-4.82-4.96-4.76-19.79
PBT33.9931.6522.3518.4517.0489.49
Tax-8.37-6.36-6.35-4.34-5.10-22.15
Equity0.000.000.000.000.000.00
OPM20.9420.1818.1116.5815.2918.00
Net Profit25.6325.2916.0114.1211.9367.35
NPM15.7816.1312.9712.6810.713
EPS24.724.3715.4313.6064.9
Consolidated
TypeDec-25Sep-25Jun-25Mar-25Dec-24FY24-25
Revenue123.44111.05111.48115.6884.41370.197
Other Income0.530.900.380.770.661.92
Total Income123.97111.95111.86116.4485.06372.12
Interest0.002.842.762.492.209.88
Expenditure-100.79-93.50-94.80-97.30-73.67-317.98
PBDT0.000.000.000.000.000.00
Depreciation0.00-4.96-4.77-5.09-4.56-18.29
PBT22.3518.4517.0319.0811.3954.14
Tax-6.35-4.34-5.10-4.50-2.87-14.34
Equity0.000.000.000.000.0010.38
OPM18.0216.4815.2216.3813.3914.55
Net Profit1614.1211.9214.488.5239.8
NPM12.9112.6110.6612.4410.0210.7
EPS013.611.4913.958.2138.36
Annual Reports

Corporate Action
Quarterly Result
Dividend
YearDividend TypeAmountRemarkEx Date
2017Interim Divvidend0.60Interim Dividend - Rs. - 0.600005 Jan 2017
Bonus
YearRatioRemarkEx Date
20171:1Bonus issue 1:111 Oct 2017
Split

Mutual Fund Holddings